Brief: Brain Biotech And Sartorius To Jointly Research And Adapt Novel CRISPR Cas-Nucleases
28/07/2021 07:32
July 28 (Reuters) - BRAIN BIOTECH AG BNNn.DE :
* SARTORIUS AND BRAIN JOINTLY RESEARCHING AND ADAPTING NOVEL
CRISPR CAS-NUCLEASES
Source text for Eikon: ID:nEQzMpjXa
Further company coverage: BNNn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on BRAIN Biotech AG
See all newsBrief: BRAIN Biotech 9M EBITDA EUR -1.6 Million
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt